2021/3053(DEA)
Derogation from the obligation of wholesalers to decommission the unique identifier of medicinal products exported to the United Kingdom
Basic information
2021/3053(DEA)
DEA - Delegated acts procedure
Supplementing 1999/0134(COD)
Subject
4.20.01 Medicine, diseases
4.20.04 Pharmaceutical products and industry
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 17/12/2021 | Non-legislative basic document published | C(2021)09700 | |
| 17/12/2021 | Initial period for examining delegated act 2.0 month(s) | ||
| 19/01/2022 | Committee referral announced in Parliament | ||
| 25/02/2022 | Delegated act not objected by Parliament |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2021/3053(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Supplementing 1999/0134(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ENVI/9/08017
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2021)09700 17/12/2021